India cuts cancer drug prices after court ruling on mark-ups
India has lowered the cost of cancer drugs. The move follows a court ruling that called the high mark-ups extortion.
பின்னணிCancer drugs are often expensive, and India's drug pricing is regulated by the government through a national list of essential medicines. Courts have stepped in before to question high prices, and pricing disputes over medicines are a recurring issue in the country's healthcare debate.
The Guardian-இல் படிக்க (ஆங்கிலம்)
பர்னிங் பொட்டேட்டோ ஸ்கோர்: 52%